Specific 14-3-3 isoform detection and immunolocalization in prion diseases

被引:31
作者
Baxter, HC
Fraser, JR
Liu, WG
Forster, JL
Clokie, S
Steinacker, P
Otto, M
Bahn, E
Wiltfang, J
Aitken, A
机构
[1] Univ Edinburgh, Dept Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland
[2] Inst Anim Hlth, Neuropathogenesis Unit, Edinburgh EH9 3JF, Midlothian, Scotland
[3] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany
[4] Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany
[5] Univ Gottingen, Dept Psychiat, D-37075 Gottingen, Germany
关键词
CSF; ELISA; immunocytochemistry; neurodegeneration;
D O I
10.1042/bst0300387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
14-3-3 proteins are involved in signalling processes in neuronal cells. Using isoform-specific antibodies we have examined the variation in 14-3-3 isoform neurolocation in normal and scrapie-infected murine brain and show that in defined areas of the brain there are significant changes associated with the pathology of the disease process. The appearance of 14-3-3 proteins in the cerebrospinal fluid (CSF) is a consequence of neuronal disease and the detection of specific isoforms of the 14-3-3 proteins in the CSF is characteristic of some neurodegenerative diseases. In this study, monitoring specifically for the gamma 14-3-3 isoform in the CSF by both Western-blot analysis and ELISA we can show a level of correlation between the assays.
引用
收藏
页码:387 / 391
页数:5
相关论文
共 28 条
[1]   14-3-3-ALPHA AND 14-3-3-DELTA ARE THE PHOSPHORYLATED FORMS OF RAF-ACTIVATING 14-3-3-BETA AND 14-3-3-ZETA - IN-VIVO STOICHIOMETRIC PHOSPHORYLATION IN BRAIN AT A SER-PRO-GLU-LYS MOTIF [J].
AITKEN, A ;
HOWELL, S ;
JONES, D ;
MADRAZO, J ;
PATEL, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5706-5709
[2]   14-3-3 and its possible role in co-ordinating multiple signalling pathways [J].
Aitken, A .
TRENDS IN CELL BIOLOGY, 1996, 6 (09) :341-347
[3]   Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain [J].
Baxter, HC ;
Liu, WG ;
Forster, JL ;
Aitken, A ;
Fraser, JR .
NEUROSCIENCE, 2002, 109 (01) :5-14
[4]  
Fountoulakis M, 1999, J NEURAL TRANSM-SUPP, P323
[5]   The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies [J].
Hsich, G ;
Kinney, K ;
Gibbs, CJ ;
Lee, KH ;
Harrington, MG .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (13) :924-930
[6]   MOLECULAR-CLONING OF CDNA CODING FOR BRAIN-SPECIFIC 14-3-3 PROTEIN, A PROTEIN KINASE-DEPENDENT ACTIVATOR OF TYROSINE AND TRYPTOPHAN HYDROXYLASES [J].
ICHIMURA, T ;
ISOBE, T ;
OKUYAMA, T ;
TAKAHASHI, N ;
ARAKI, K ;
KUWANO, R ;
TAKAHASHI, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) :7084-7088
[7]   CHEMISTRY AND CELL BIOLOGY OF NEURON-SPECIFIC AND GLIA-SPECIFIC PROTEINS [J].
ISOBE, T ;
ICHIMURA, T ;
OKUYAMA, T .
ARCHIVES OF HISTOLOGY AND CYTOLOGY, 1989, 52 :25-32
[8]   EXPRESSION AND STRUCTURAL-ANALYSIS OF 14-3-3-PROTEINS [J].
JONES, DHA ;
MARTIN, H ;
MADRAZO, J ;
ROBINSON, KA ;
NIELSEN, P ;
ROSEBOOM, PH ;
PATEL, Y ;
HOWELL, SA ;
AITKEN, A .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 245 (04) :375-384
[9]   14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains [J].
Kawamoto, Y ;
Akiguchi, I ;
Nakamura, S ;
Honjyo, Y ;
Shibasaki, H ;
Budka, H .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (03) :245-253
[10]  
Kenney K, 2000, ANN NEUROL, V48, P395, DOI 10.1002/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO